Fear of cancer recurrence eight years after early-stage breast cancer – results from a national survey

References

• WHO. Breast Cancer 2021.
   Google Scholar
• Norway CRo. Cancer in Norway 2021 - Cancer incidence, mortality, survival and prevalence in Oslo, Norway. 2022.
   Google Scholar
• Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265–3268. doi: 10.1007/s00520-016-3272-5.
   PubMed Web of Science ®Google Scholar
• Thewes B, Butow P, Zachariae R, et al. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571–587. doi: 10.1002/pon.2070.
   PubMed Web of Science ®Google Scholar
• Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–322. doi: 10.1007/s11764-013-0272-z.
   PubMed Web of Science ®Google Scholar
• Luigjes-Huizer YL, Tauber NM, Humphris G, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology. 2022;31(6):879–892. doi: 10.1002/pon.5921.
   PubMed Web of Science ®Google Scholar
• Lebel S, Beattie S, Arès I, et al. Young and worried: age and fear of recurrence in breast cancer survivors. Health Psychol. 2013;32(6):695–705. doi: 10.1037/a0030186.
   PubMed Web of Science ®Google Scholar
• Chirico A, Vizza D, Valente M, et al. Assessing the fear of recurrence using the cancer worry scale in a sample of italian breast cancer survivors. Support Care Cancer. 2022;30(3):2829–2837. doi: 10.1007/s00520-021-06718-4.
   PubMed Web of Science ®Google Scholar
• Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (>/= 5 years) cancer survivors–a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11. doi: 10.1002/pon.3022.
   PubMed Web of Science ®Google Scholar
• Schapira L, Zheng Y, Gelber SI, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128(2):335–343. doi: 10.1002/cncr.33921.
   PubMed Web of Science ®Google Scholar
• Tauber NM, O'Toole MS, Dinkel A, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and Meta-Analysis. J Clin Oncol. 2019;37(31):2899–2915. doi: 10.1200/JCO.19.00572.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi: 10.1016/S0140-6736(07)61602-X.
   PubMed Web of Science ®Google Scholar
• Gotay CC, Pagano IS. Assessment of survivor concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5:15. doi: 10.1186/1477-7525-5-15.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Lagergren J. The charlson comorbidity index in registry-based research. Methods Inf Med. 2017;56(5):401–406. doi: 10.3414/ME17-01-0051.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The european organization for research and treatment of cancer QLQ-C30: a quality-of-Life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.
   PubMed Web of Science ®Google Scholar
• Giesinger JM, Loth FLC, Aaronson NK, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol. 2020;118:1–8. doi: 10.1016/j.jclinepi.2019.10.003.
   PubMed Web of Science ®Google Scholar
• Sprangers MA, Groenvold M, Arraras JI, et al. The european organization for research and treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–2768. doi: 10.1200/JCO.1996.14.10.2756.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092.
   PubMed Web of Science ®Google Scholar
• Unit QCQoL. EORTC QLQ-C30 Scoring Manual. In: EORTC, editor. Brussels2001.
   Google Scholar
• Shin C, Ko YH, An H, et al. Normative data and psychometric properties of the patient health questionnaire-9 in a nationally representative Korean population. BMC Psychiatry. 2020;20(1):194. doi: 10.1186/s12888-020-02613-0.
   PubMed Web of Science ®Google Scholar
• Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–251. doi: 10.1007/s00520-008-0444-y.
   PubMed Web of Science ®Google Scholar
• Smith AB, Costa D, Galica J, et al. Spotlight on the fear of cancer recurrence inventory (FCRI). Psychol Res Behav Manag. 2020;13:1257–1268. doi: 10.2147/PRBM.S231577.
   PubMed Web of Science ®Google Scholar
• Mutsaers B, Butow P, Dinkel A, et al. Identifying the key characteristics of clinical fear of cancer recurrence: an international delphi study. Psychooncology. 2020;29(2):430–436. doi: 10.1002/pon.5283.
   PubMed Web of Science ®Google Scholar
• Ellegaard MB, Grau C, Zachariae R, et al. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncol. 2017;56(2):314–320. doi: 10.1080/0284186X.2016.1268714.
   PubMed Web of Science ®Google Scholar
• Vandraas KF, Reinertsen KV, Kiserud CE, et al. Fear of cancer recurrence among young adult cancer survivors-exploring long-term contributing factors in a large, population-based cohort. J Cancer Surviv. 2021;15(4):497–508.
   PubMed Web of Science ®Google Scholar
• Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20(11):2651–2659. doi: 10.1007/s00520-011-1371-x.
   PubMed Web of Science ®Google Scholar
• Ankersmid JW, Lansink Rotgerink FK, Strobbe LJA, et al. Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors. Breast Cancer Res Treat. 2022;195(2):117–125. doi: 10.1007/s10549-022-06684-3.
   PubMed Web of Science ®Google Scholar
• Beadle BM, Woodward WA, Buchholz TA. The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol. 2011;21(1):26–34. doi: 10.1016/j.semradonc.2010.09.001.
   PubMed Web of Science ®Google Scholar
• Ness S, Kokal J, Fee-Schroeder K, et al. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013;40(1):35–42. doi: 10.1188/13.ONF.35-42.
   PubMed Web of Science ®Google Scholar
• Palesh O, Aldridge-Gerry A, Ulusakarya A, et al. Sleep disruption in breast cancer patients and survivors. J Natl Compr Canc Netw. 2013;11(12):1523–1530. doi: 10.6004/jnccn.2013.0179.
   PubMed Web of Science ®Google Scholar
• Berrett-Abebe J, Cadet T, Pirl W, et al. Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol. 2015;33(3):297–309. doi: 10.1080/07347332.2015.1020586.
   PubMed Web of Science ®Google Scholar
• Bergerot CD, Philip EJ, Bergerot PG, et al. Fear of cancer recurrence or progression: what is it and what can We do about it? Am Soc Clin Oncol Educ Book. 2022;42:1–10. doi: 10.1200/EDBK_100031.
   PubMedGoogle Scholar
• Akechi T, Yamaguchi T, Uchida M, et al. Smartphone psychotherapy reduces fear of cancer recurrence among breast cancer survivors: a fully decentralized randomized controlled clinical trial (J-SUPPORT 1703 study). J Clin Oncol. 2023;41(5):1069–1078. doi: 10.1200/JCO.22.00699.
   PubMed Web of Science ®Google Scholar
• Park S, Sato Y, Takita Y, et al. Mindfulness-Based cognitive therapy for psychological distress, fear of cancer recurrence, fatigue, spiritual Well-Being, and quality of life in patients with breast Cancer-A randomized controlled trial. J Pain Symptom Manage. 2020;60(2):381–389. doi: 10.1016/j.jpainsymman.2020.02.017.
   PubMed Web of Science ®Google Scholar
• Schell LK, Monsef I, Wöckel A, et al. Mindfulness-based stress reduction for women diagnosed with breast cancer. Cochrane Database Syst Rev. 2019;3(3):Cd011518. doi: 10.1002/14651858.CD011518.pub2.
   PubMedGoogle Scholar
• Reich RR, Lengacher CA, Alinat CB, et al. Mindfulness-Based stress reduction in post-treatment breast cancer patients: immediate and sustained effects across multiple symptom clusters. J Pain Symptom Manage. 2017;53(1):85–95. doi: 10.1016/j.jpainsymman.2016.08.005.
   PubMed Web of Science ®Google Scholar
• Guo Y, Kopec JA, Cibere J, et al. Population survey features and response rates: a randomized experiment. Am J Public Health. 2016;106(8):1422–1426. doi: 10.2105/AJPH.2016.303198.
   PubMed Web of Science ®Google Scholar
• Lie HC, Rueegg CS, Fossa SD, et al. Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the nor-CAYACS study. J Cancer Surviv. 2019;13(3):353–363. doi: 10.1007/s11764-019-00757-x.
   PubMed Web of Science ®Google Scholar